PPT-RESEARCH INVOLVING PREGNANT WOMEN AND FETUSES

UAMS IRB Reviewer Training July 2019 What has changed and what hasnt regarding pregnant women in research Pre2018 Common Rule aka the Old Rule pregnant women were included in the list of populations vulnerable to undue influence or coercion along with children prisoners and the mentally disabled 45CFR46111b. Bill G. . Kapogiannis. , MD, FAAP. Pediatric, Adolescent & Maternal AIDS (PAMA) Branch. Eunice Kennedy Shriver . National Institute of Child Health and Human Development, NIH . Bethesda, MD. Disclosures of Financial Relationships. Antenatal Care (2016). Overview. Reproductive Health and Research (RHR). Nutrition for Health and Development (NHD). Maternal, Newborn, Child and Adolescent Health (MCA). Geneva, Switzerland. Outline. Pregnant Women. Permissible Regulations, Cautious Practice:. A US Perspective. Anna C. Mastroianni, JD, MPH. Professor of Law, University of Washington School of Law. Associate Director, Institute for Public Health Genetics. Antenatal Care (2016). Overview. Reproductive Health and Research (RHR). Nutrition for Health and Development (NHD). Maternal, Newborn, Child and Adolescent Health (MCA). Geneva, Switzerland. Outline. Testing and Using a Live Vaccine in Pregnancy?. Carleigh Krubiner, PhD. Johns Hopkins Berman Institute of Bioethics. Global Forum on Bioethics in Research. Buenos Aires, Argentina. November 3, 2016. Funded. and . Postpartum Co-infected . Women . Core Competency 5: Subpopulations . of HIV/HCV . Co-infected . Persons. Lesson Objectives. At the end of this section, participants will be able to:. Know the recommendations for HCV testing in pregnant women and in HCV-exposed infants and children. . Meinuo Chen and Anna Palatnik, MD. Medical College of Wisconsin, Department of Obstetrics & Gynecology. ABSTRACT. METHODS. RESULTS. BACKGROUND. OBJECTIVE. Conclusion. WOMEN. Project Overview. Principal Investigator: Afshan Hameed, MD, FACOG. UCI Co-Investigators: Heike Thiel de Bocanegra, PhD, MPH. Brian Crosland, MD. UCSD Co-Investigator: Maryam . Tarsa. , MD, MAS. effect on infection rate among primiparous and multiparous women. . September 29, 20. 15. Hokkaido University Graduate School of Medicine. , Japan. . Takahiro Yamada. . Today’s. . presentation. Naomi Waddell. Professor . Thanos. . Karatzias. , Professor Michael Brown, Dr Catherine Mahoney . School . of Nursing, Midwifery & Social Care, Edinburgh Napier . University. Literature review. Drugs in Pregnant Women. Incidence. 90% of pregnant women have or develop medical problems that require them to take more than one prescription drug during pregnancy. . (Shephard & Lemire, 2007). women: . Lessons . learned . and . an overview of programmatic . challenges”. Presented by:. Agnes Mahomva, . MBChB. , MPH. Country Director , EGPAF . Zimbabwe . International AIDS Conference, . Durban, South Africa. , in . OR Tambo Municipality. Problem. We as O R Tambo municipality failed to reach millennium developmental goal number 5(Improved health for pregnant women ). Issues of concern . Medical causes:. Don’t Know Key Facts about Zika Virus. n=105. Not aware of association with microcephaly. Not aware virus can be sexually transmitted. Believe infected individuals are “very likely” to show symptoms.